US$ 22.98
bpc-157 fda approval status warning unapproved peptide bpc-157 fda warning not approved FDA Compliance for Peptide Therapy and BPC-157 – Holt Law bpc-157 fda warning news FDA
Description
MOTS-c is prohibited by WADA under category S4: Hormone and Metabolic Modulators
It suggests to me that you were given it when you didn't need it and if this is the case I'm not surprised at your skin's reaction

Conclusion: Preclinical Horizons in Incretin and Repair Assays While empirical anecdotal feedback in private forums frequently highlights the efficiency of BPC-157 in tissue repair models, human clinical testing remains strictly outside current scientific parameters
Individuals with known allergies to any of the *B vitamins* or other components of the injection should avoid its use
no separate PDA trial base as of April 2026

1 2 3 "What everyone should know about Zostavax"
